Efficacy of lipid soluble, membrane-protective agents against hydrogen peroxide cytotoxicity in cardiac myocytes

Free Radical Biology and Medicine

Volumn 21, Issue 6, 1996, Pages 743-753

  Horwitz, Lawrence D ^a   Wallner, Juliann S ^a   Decker, Douglas E ^b   Buxser, Stephen E ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 AMINOSTEROID; 21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; DILTIAZEM; FREE RADICAL; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; LIDOCAINE; MEMBRANE PROTECTIVE AGENT; PROBUCOL; PROPRANOLOL; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CHICKEN; DRUG CYTOTOXICITY; FETOTOXICITY; FETUS; HEART MUSCLE CELL; LIPID PEROXIDATION; LIPID SOLUBILITY; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; GALLUS GALLUS;

EID: 0029857594     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00177-3     Document Type: Article

References (45)

1. 1. Boveris, A.; Chance, B. The mitochondrial generation of hydrogen peroxide: General properties and effect of hyperbaric oxygen. Biochem. J. 134:707-716; 1973.
2. 2. Janero, D. R.; Hreniuk, D.; Sharif, H. M. Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): Lethal peroxidative membrane injury. J. Cell. Physiol. 149:347-364; 1991.
3. 3. Entman, M. L.; Youker, K.; Shoji, T.; Shappel, S. B.; Siegel, C.; Rothlein, R.; Dreyer, W. J.; Schmalstieg, F. C.; Smith, C. W. Neutrophil adherence to isolated canine myocytes. Evidence for a CD-18-dependent mechanism. J. Clin. Invest. 85:1497-1506; 1990.
4. 4. Byler, R. M.; Sherman, N. A.; Wallner, J. S.; Horwitz, L. D. Hydrogen peroxide cytotoxicity in cultured cardiac myocytes is iron dependent. Am. J. Physiol. 266:H121-H127; 1994.
5. 5. Braughler, J. M.; Pregenzer, J. F.; Chase, R. L.; Duncan, L. A.; Jacobsen, E. J.; McCall, J. M. Novel 21-amino-substituted steroids as potent inhibitors of iron dependent lipid peroxidation. J. Biol. Chem. 262:10438-10440; 1987.
6. 6. Lesnefsky, E. J.; Allen, K. G. D.; Carrea, F. P.; Horwitz, L. D. Iron-catalyzed reactions cause lipid peroxidation in the intact heart. J. Mol. Cell. Cardiol. 24:1031-1038; 1992.
7. 7. Jolly, S. R.; Kane, W. J.; Baillie, M. B.; Adams, G. D.; Lucchesi, B. R. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase.. Circ. Res. 54:277-285; 1984.
8. 8. Lesnefsky, E. J.; Repine, J. E.; Horwitz, L. D. Deferoxamine pretreatment reduces canine infarct size and oxidative injury. J. Pharmacol, Exp. Ther. 253:1103-1109; 1990.
9. 9. Horwitz, L. D.; Fennessey, P. V.; Shikes, R. H.; Kong, Y. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation 89:1792-1801; 1994.
10. 10. Lesnefsky, E. J.; VanBenthuysen, K. M.; McMurtry, I. F.; Shikes, R. H.; Johnston, R. B., Jr.; Horwitz, L.D. Lidocaine reduces canine infarct size and decreases release of a lipid peroxidation product. J. Cardiovasc. Pharmacol 13:895-901; 1989.
11. 11. Janero, D. R.; Burghardt, B.; Lopez, R. Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists. Biochem. Pharmacol. 37:4197-4203; 1988.
12. 12. Mak, I. T.; Weglicki, W. B. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ. Res. 66:1449-1452; 1990.
13. 13. Mak, I. T.; Weglicki, W. B. Inhibition of sarcolemmal carbon-centered free radical formation by propanolol. Circ. Res. 65:1151-1156; 1989.
14. 14. Mickle, D. A.; Li, R. K.; Weisel, R. D.; Birnbaum, P. L.; Wu, T. W.; Jackowski, G.; Madonik, M. M.; Burton, G. W.; Ingold, K. U. Myocardial salvage with Trolox and ascorbic acid for an acute evolving infarction. Ann. Thorac. Surg. 47:533-537; 1989.
15. 15. Massey, K.; Burton, K. Free radical damage in neonatal rat cardiac myocyte cultures: Effects of alpha-tocopherol, Trolox and phytol. Free Radic. Biol. Med. 8:449-458; 1990.
16. 16. Rubenstein, J. D.; Lesnefsky, E. J.; Byler, R. M.; Fennessey, P. V.; Horwitz, L. D.; Trolox, C. A lipid-soluble membrane protective agent, attenuates myocardial injury from ischemia and reperfusion.. Free Radic. Biol. Med. 13:627-634; 1992.
17. 17. Scott, J. W.; Cort, W. M.; Harley, H.; Parrish, D. R.; Saucy, G. 6-Hydroxychroman-2-carboxylic acids: Novel antioxidants. J. Am. Oil Chem. Soc. 51:200-203; 1974.
18. 18. Kuzuya, M.; Naito, M.; Funaki, C.; Hayashi, T.; Asai, K.; Kuzuya, F. Probucol prevents oxidative injury to endothelial cells. J. Lipid Res. 32:197-204; 1991.
19. 19. Gotoh, N.; Shimizu, K.; Komuro, E.; Tsuchiya, J.; Noguchi, N.; Niki, E. Antioxidant activities or probucol against lipid peroxidation. Biochem. Biophys. Acta 1128:147-54; 1992.
20. 20. Carrea, F. P.; Lesnefsky, E. J.; Kaiser, D. G.; Horwitz, L. D. The lazaroid U74006F, a 21 aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion. J. Cardiovasc. Pharmacol 20:230-235; 1992.
21. 21. Lesnefsky, E. J.; Dauber, I. M.; Horwitz, L. D. Myocardial sulfhydryl pool alterations occur during reperfusion after brief and prolonged myocardial ischemia in vivo. Circ. Res. 68:605-613; 1991.
22. 22. Janero, D. R.; Hreniuk, D.; Sharif, H. M.; Prout, K. C. Hydroperoxide-induced oxidative stress alters pyridine nucleotide metabolism in neonatal heart muscle cells. Am. J. Physiol. 264:C1401-C1410; 1993.
23. 23. Kong, Y.; Lesnefsky, E. J.; Ye, J.; Horwitz, L. D. Prevention of lipid peroxidation does not prevent oxidant-induced myocardial contractile dysfunction. Am. J. Physiol. 267:H2371-H2377; 1994.
24. 24. Allen, K. G. D.; Huang, C. J.; Morin, C. L. Determination of picomole quantities of hydroperoxides by a coupled glutathione peroxidase and glutathione disulfide specific glutathione reductase assay. Annal. Biochem. 186:108-111; 1990.
25. 25. Bradford, M. M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254; 1976.
26. 26. McKenna, R.; Kezdy, F. J.; Epps, D. E. Kinetic analysis of the free radical-induced lipid peroxidation in human erythrocyte membranes: Evaluation of potential antioxidants using cis-parinaric acid to monitor peroxidation. Anal. Biochem. 196:443-450; 1991.
27. 27. Vroegop, S. M.; Decker, D. E.; Buxser, S. E. Localization of damage induced by reactive oxygen species in cultured cells. Free Radic. Biol. Med. 18:141-151; 1995.
28. 28. Campbell, A. K. The Rubicon hypothesis: A quantal framework for understanding the molecular pathway of cell activation and injury. In: Calcium, oxygen radicals, and cellular damage. Cambridge: Cambridge University; 1991:189-217.
29. 29. Yamaoka, K.; Tanigawara, Y.; Nakagawa, T.; Uno, T. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharm. Dyn. 4:879-84; 1981.
30. 30. Kennedy, W. J., Jr.; Gentle, J. E.. In: Statistical computing. New York: Marcel Dekker; 1980:90-92.
31. 31. Buxser, S. Optimizing biological activity of lipophilic compounds in cultured cells by improving delivery: Theoretical and practical considerations. Neuroprotocols 3:165-174; 1993.
32. 32. Wu, T.-W.; Hashimoto, N.; Wu, J.; Carey, D.; Li, R.-K.; Mickle, D. A.; Weisel, R. D. The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochem. Cell. Biol. 68:1189-1194; 1990.
33. 33. Peck, S. L.; Johnston, R. B., Jr.; Horwitz, L. D. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine. J. Pharmacol. Exp. Ther. 235:418-422; 1985.
34. 34. Goldstein, I. M.; Lind, S.; Hoffstein, S.; Weissman, G. Influence of local anaesthetics upon human polymorphonuclear leukocyte function in vitro: Reduction of lysosomal enzyme release and superoxide anion production. J. Exp. Med. 146:483-494; 1977.
35. 35. Hall, E. D.; McCall, J. M.; Means, E, D. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. In: Advances in Pharmacology. San Diego: Academic Press; 1994:221-268.
36. 36. Braughler, J. M.; Pregenzer, J. F. The 21-aminosteroid inhibitors of lipid peroxidation: Reactions with lipid peroxyl and phenoxyl radicals. Free Radic Biol. Med. 7:125-130; 1989.
37. 37. McCay, P. B. Vitamin E: Interactions with free radicals and ascorbate. Annu. Rev. Nutr. 5:323-340: 1985.
38. 38. Janero, D. A.; Cohen, N.; Burghardt, B.; Schaer, B. H. Novel 6-hydroychroman-2-carbonitrile inhibitors of membrane peroxidative injury. Biochem. Pharmacol. 40:551-558; 1990.
39. 39. Ingold, K. U.; Burton, G. W.; Foster, D. O.; Zuker, M.; Hughes, L.; Lacelle, S.; Lusztyk, E.; Slaby, M. A new vitamin E analogue more active than α-tocopherol in the rat curative myopathy bioassay. FEBS Lett. 205:117-120; 1986.
40. 40. Kalyanaraman, B.; Darley-Usmar, V.M.; Wood, J.; Joseph, J.; Parthasarathy, S. Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein. J. Biol. Chem. 267:6789-6795; 1992.
41. 41. Janero, D.R. Malondialdehyde and thiobarbituric-acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9:515-540: 1991.
42. 42. Weglicki, W.B.; Dickens, B. F.; Mak, I. T. Enhanced lysosomal phospholipid degradation and lysophospholipid production due to free radicals. Biochem Biophys Res Commun 124:229-233; 1984.
43. 43. Das, D.K; Iyengar, J.; Jones, R.M.; Lu, D.; Maity, S. Protection from nonfreezing cold injury by quinacrine, a phospholipase inhibitor. Cryobiology 28:177-184; 1991.
44. 44. Decker, D.E.; Vroegop, S.M.; Goodman, T.G.; Peterson, T.; Buxser, S.E. Kinetics and thermodynamics of emulsion delivery of lipophilic antioxidants to cells in culture. Chem. Phys. Lipids 76:7-25; 1995.
45. 45. Burton, K. P.P. Effects of 21-aminosteroids in neonatal rat cardiac myocyte cell cultures exposed to free radicals. Cardiovasc. Res. 28:1500-1506; 1994.